Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp EBITDA per Share

The EBITDA per Share of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Oct 5, 2026 is 0.43 CNY. In the previous year, EBITDA per Share was 0.50 CNY — a change of -13.51% (lower).

EBITDA per Share

0.43CNY

YoY

-13.51%

Last updated:

EBITDA per Share of Vcanbio Cell & Gene Engineering Corp is 2026 0.43 CNY. EBITDA per Share of Vcanbio Cell & Gene Engineering Corp was 2025 0.50 CNY. It decreases by -13.51% lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.29 CNY
Jan 1, 2019
0.41 CNY
Jan 1, 2020
-0.04 CNY
Jan 1, 2021
0.63 CNY
Jan 1, 2022
0.52 CNY
Jan 1, 2023
0.47 CNY
Jan 1, 2024
0.50 CNY
Jan 1, 2025
0.43 CNY
The Vcanbio Cell & Gene Engineering Corp EBITDA per Share history
YEAREBITDA per ShareYoY
0.43CNY-13.51%
0.50CNY+6.07%
0.47CNY-8.82%
0.52CNY-18.56%
0.63CNY-1,652.43%
-0.04CNY-110.02%
0.41CNY+42.66%
0.29CNY-20.33%
0.36CNY+13.95%
0.31CNY-56.73%
0.73CNY+231.41%
0.22CNY—
Access this data via the Eulerpool API
Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

EBITDA per Share of Vcanbio Cell & Gene Engineering Corp is 0.43 CNY in 2026.

EBITDA per Share of Vcanbio Cell & Gene Engineering Corp changed from 0.50 CNY to 0.43 CNY, representing a -13.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Vcanbio Cell & Gene Engineering Corp

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vcanbio Cell & Gene Engineering Corp